Angelousi A, Kassi E, Ansari-Nasiri N, Randeva H, Kaltsas G, Chrousos G (2019) Clock genes and cancer development in particular in endocrine tissues. Endocr Relat Cancer 26(6):R305–R317. https://doi.org/10.1530/ERC-19-0094
Article CAS PubMed Google Scholar
Bhatti P, Zhang Y, Song X, Makar KW, Sather CL, Kelsey KT, Houseman EA, Wang P (2015) Nightshift work and genome-wide DNA methylation. Chronobiol Int 201532(1):103–112. https://doi.org/10.3109/07420528.2014.956362
Boucai L, Seshan V, Williams M, Knauf JA, Saqcena M, Ghossein RA, Fagin JA (2022) Characterization of subtypes of BRAF-mutant papillary thyroid cancer defined by their thyroid differentiation score. J Clin Endocrinol Metab 107(4):1030–1039. https://doi.org/10.1210/clinem/dgab851
Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159(3):676–690. https://doi.org/10.1016/j.cell.2014.09.050
Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR (2023) Thyroid cancer. Lancet 401(10387):1531–1544. https://doi.org/10.1016/S0140-6736(23)00020-X
Cheng SP, Lee JJ, Chang YC, Lin CH, Li YS, Liu CL (2020) Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer. J Pathol 252(2):114–124. https://doi.org/10.1002/path.5503
Article CAS PubMed Google Scholar
Cheng SY, Hsu YC, Cheng SP (2023a) Trends in thyroid cancer burden in Taiwan over two decades. Cancer Causes Control 34(6):553–561. https://doi.org/10.1007/s10552-023-01694-y
Article PubMed Central PubMed Google Scholar
Cheng SY, Huang SY, Cheng SP (2023b) Acute exposure to diesel particulate matter promotes collective cell migration in thyroid cancer cells. Front Toxicol 5:1294760. https://doi.org/10.3389/ftox.2023.1294760
Article PubMed Central PubMed Google Scholar
Cheong JK, Nguyen TH, Wang H, Tan P, Voorhoeve PM, Lee SH, Virshup DM (2011) IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ε and Wnt/β-catenin independent inhibition of mitotic spindle formation. Oncogene 30(22):2558–2569. https://doi.org/10.1038/onc.2010.627
Article CAS PubMed Central PubMed Google Scholar
Chien IA, Hsu YC, Tsai CH, Cheng SP (2024) Population-based analysis of the human development index and risk factors for head and neck cancer. Head Neck 46(4):889–895. https://doi.org/10.1002/hed.27639
Dibner C, Sadowski SM, Triponez F, Philippe J (2017) The search for preoperative biomarkers for thyroid carcinoma: application of the thyroid circadian clock properties. Biomark Med 11(3):285–293. https://doi.org/10.2217/bmm-2016-0316
Article CAS PubMed Google Scholar
Fahrenkrug J, Georg B, Hannibal J, Jorgensen HL (2017) Hypophysectomy abolishes rhythms in rat thyroid hormones but not in the thyroid clock. J Endocrinol 233(3):209–216. https://doi.org/10.1530/JOE-17-0111
Article CAS PubMed Central PubMed Google Scholar
Fontana R, Mestre-Farrera A, Yang J (2024) Update on epithelial-mesenchymal plasticity in cancer progression. Annu Rev Pathol 19:133–156. https://doi.org/10.1146/annurev-pathmechdis-051222-122423
Article CAS PubMed Google Scholar
Haase J, Misiak D, Bauer M, Pazaitis N, Braun J, Potschke R, Mensch A, Bell JL, Dralle H, Siebolts U, Wickenhauser C, Lorenz K, Huttelmaier S (2021) IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. Mod Pathol 34(1):32–41. https://doi.org/10.1038/s41379-020-0630-0
Article CAS PubMed Google Scholar
Hsu YC, Cheng SY, Chien MN, Cheng SP (2023a) Impact of social and economic factors on global thyroid cancer incidence and mortality. Eur Arch Otorhinolaryngol 280(9):4185–4193. https://doi.org/10.1007/s00405-023-07992-0
Hsu YC, Huang WC, Kuo CY, Li YS, Cheng SP (2023b) Downregulation of cellular retinoic acid binding protein 1 fosters epithelial-mesenchymal transition in thyroid cancer. Mol Carcinog 62(12):1935–1946. https://doi.org/10.1002/mc.23626
Article CAS PubMed Google Scholar
Ikegami K, Refetoff S, Van Cauter E, Yoshimura T (2019) Interconnection between circadian clocks and thyroid function. Nat Rev Endocrinol 15(10):590–600. https://doi.org/10.1038/s41574-019-0237-z
Article PubMed Central PubMed Google Scholar
Kim SY, Dunn IF, Firestein R, Gupta P, Wardwell L, Repich K, Schinzel AC, Wittner B, Silver SJ, Root DE, Boehm JS, Ramaswamy S, Lander ES, Hahn WC (2010) CK1epsilon is required for breast cancers dependent on beta-catenin activity. PLoS One 5(2):e8979. https://doi.org/10.1371/journal.pone.0008979
Article CAS PubMed Central PubMed Google Scholar
Kuo CY, Chang YC, Chien MN, Jhuang JY, Hsu YC, Huang SY, Cheng SP (2021) SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway. Endocr Relat Cancer 29(2):47–58. https://doi.org/10.1530/ERC-21-0256
Kuo CY, Hsu YC, Liu CL, Li YS, Chang SC, Cheng SP (2023) SOX4 is a pivotal regulator of tumorigenesis in differentiated thyroid cancer. Mol Cell Endocrinol 578:112062. https://doi.org/10.1016/j.mce.2023.112062
Article CAS PubMed Google Scholar
Kuo CY, Tsai CH, Wu JK, Cheng SP (2024) Sublethal thermal stress promotes migration and invasion of thyroid cancer cells. PLoS One 19(2):e0298903. https://doi.org/10.1371/journal.pone.0298903
Article CAS PubMed Central PubMed Google Scholar
Kuo CY, Hsu YC, Chen MJ, Lin CH, Li YS, Cheng SP (2025) Glucose transporter 1 inhibitors induce autophagy and synergize with lenvatinib in thyroid cancer cells. Head Neck 47(2):615–624. https://doi.org/10.1002/hed.27953
Lai H, Xiang X, Long X, Chen Z, Liu Y, Huang X (2024) Multi-omics and single-cell sequencing analyses reveal the potential significance of circadian pathways in cancer therapy. Expert Rev Mol Diagn 24(1–2):107–121. https://doi.org/10.1080/14737159.2023.2296668
Article CAS PubMed Google Scholar
Liu CL, Hsu YC, Kuo CY, Jhuang JY, Li YS, Cheng SP (2022) CRABP2 is associated with thyroid cancer recurrence and promotes invasion via the integrin/FAK/AKT pathway. Endocrinology. https://doi.org/10.1210/endocr/bqac171
Article PubMed Central PubMed Google Scholar
Lu L, Wang JR, Henderson YC, Bai S, Yang J, Hu M, Shiau CK, Pan T, Yan Y, Tran TM, Li J, Kieser R, Zhao X, Wang J, Nurieva R, Williams MD, Cabanillas ME, Dadu R, Busaidy NL, Zafereo M, Navin N, Lai SY, Gao R (2023) Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J Clin Invest 133(11):e169653. https://doi.org/10.1172/JCI169653
Article CAS PubMed Central PubMed Google Scholar
Makhlouf AM, Chitikova Z, Pusztaszeri M, Berczy M, Delucinge-Vivier C, Triponez F, Meyer P, Philippe J, Dibner C (2016) Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma. Oncotarget 7(29):45776–45788. https://doi.org/10.18632/oncotarget.10166
Article PubMed Central PubMed Google Scholar
Mannic T, Meyer P, Triponez F, Pusztaszeri M, Le Martelot G, Mariani O, Schmitter D, Sage D, Philippe J, Dibner C (2013) Circadian clock characteristics are altered in human thyroid malignant nodules. J Clin Endocrinol Metab 98(11):4446–4456. https://doi.org/10.1210/jc.2013-2568
Article CAS PubMed Google Scholar
Masri S, Sassone-Corsi P (2018) The emerging link between cancer, metabolism, and circadian rhythms. Nat Med 24(12):1795–1803. https://doi.org/10.1038/s41591-018-0271-8
Comments (0)